The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 25, 2023

Filed:

Dec. 21, 2018
Applicant:

Deep Genomics Incorporated, Toronto, CA;

Inventors:

Hui Yuan Xiong, Toronto, CA;

Brendan Frey, Toronto, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 20/20 (2019.01); G06N 3/08 (2006.01); G06N 3/04 (2006.01); G16B 40/00 (2019.01); G16B 20/00 (2019.01); G16B 40/20 (2019.01); G16B 30/00 (2019.01); G16H 10/40 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 50/20 (2018.01); G16B 5/00 (2019.01); G16B 40/30 (2019.01); G16B 50/20 (2019.01); G16B 20/40 (2019.01); G16B 20/50 (2019.01); G06N 3/084 (2023.01); G06N 3/082 (2023.01);
U.S. Cl.
CPC ...
G16B 20/20 (2019.02); G06N 3/0454 (2013.01); G06N 3/08 (2013.01); G06N 3/084 (2013.01); G16B 5/00 (2019.02); G16B 20/00 (2019.02); G16B 20/40 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16B 40/20 (2019.02); G16B 40/30 (2019.02); G16B 50/20 (2019.02); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G06N 3/0445 (2013.01); G06N 3/082 (2013.01); G16B 20/50 (2019.02);
Abstract

We describe systems and methods for generating and training convolutional neural networks using biological sequences and relevance scores derived from structural, biochemical, population and evolutionary data. The convolutional neural networks take as input biological sequences and additional information and output molecular phenotypes. Biological sequences may include DNA, RNA and protein sequences. Molecular phenotypes may include protein-DNA interactions, protein-RNA interactions, protein-protein interactions, splicing patterns, polyadenylation patterns, and microRNA-RNA interactions, which may be described using numerical, categorical or ordinal attributes. Intermediate layers of the convolutional neural networks are weighted using relevance score sequences, for example, conservation tracks. The resulting molecular phenotype convolutional neural networks may be used in genetic testing, to identify drug targets, to identify patients that respond similarly to a drug, to ascertain health risks, or to connect patients that have similar molecular phenotypes.


Find Patent Forward Citations

Loading…